These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Novel dry powder inhaler formulation of glucagon with addition of citric acid for enhanced pulmonary delivery. Onoue S, Yamamoto K, Kawabata Y, Hirose M, Mizumoto T, Yamada S. Int J Pharm; 2009 Dec 01; 382(1-2):144-50. PubMed ID: 19703531 [Abstract] [Full Text] [Related]
24. Novel fibrillar insulin formulations for oral administration: Formulation and in vivo studies in diabetic mice. Dekel Y, Glucksam Y, Margalit R. J Control Release; 2010 Apr 02; 143(1):128-35. PubMed ID: 20043960 [Abstract] [Full Text] [Related]
25. Insulin loaded PLGA microspheres: effect of zinc salts on encapsulation, release, and stability. Manoharan C, Singh J. J Pharm Sci; 2009 Feb 02; 98(2):529-42. PubMed ID: 18548615 [Abstract] [Full Text] [Related]
26. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion. Potter C, Tian Y, Walker G, McCoy C, Hornsby P, Donnelly C, Jones DS, Andrews GP. Mol Pharm; 2015 May 04; 12(5):1377-90. PubMed ID: 25730138 [Abstract] [Full Text] [Related]
27. Production of hybrid lipid-based particles loaded with inorganic nanoparticles and active compounds for prolonged topical release. García-González CA, Sampaio da Sousa AR, Argemí A, López Periago A, Saurina J, Duarte CM, Domingo C. Int J Pharm; 2009 Dec 01; 382(1-2):296-304. PubMed ID: 19720123 [Abstract] [Full Text] [Related]
28. Preparation of active proteins, vaccines and pharmaceuticals as fine powders using supercritical or near-critical fluids. Cape SP, Villa JA, Huang ET, Yang TH, Carpenter JF, Sievers RE. Pharm Res; 2008 Sep 01; 25(9):1967-90. PubMed ID: 18581212 [Abstract] [Full Text] [Related]
29. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery. Xiong XY, Li YP, Li ZL, Zhou CL, Tam KC, Liu ZY, Xie GX. J Control Release; 2007 Jul 16; 120(1-2):11-7. PubMed ID: 17509718 [Abstract] [Full Text] [Related]
30. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. Chalasani KB, Russell-Jones GJ, Jain AK, Diwan PV, Jain SK. J Control Release; 2007 Sep 26; 122(2):141-50. PubMed ID: 17707540 [Abstract] [Full Text] [Related]
31. A one-pot method to enhance dissolution rate of low solubility drug molecules using dispersion polymerization in supercritical carbon dioxide. Galia A, Scialdone O, Filardo G, Spanò T. Int J Pharm; 2009 Jul 30; 377(1-2):60-9. PubMed ID: 19439168 [Abstract] [Full Text] [Related]
32. Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats. Salvioni L, Fiandra L, Del Curto MD, Mazzucchelli S, Allevi R, Truffi M, Sorrentino L, Santini B, Cerea M, Palugan L, Corsi F, Colombo M. Pharmacol Res; 2016 Aug 30; 110():122-130. PubMed ID: 27181095 [Abstract] [Full Text] [Related]
33. An efficient pH sensitive oral insulin delivery system enhanced by deoxycholic acid. Zhao L, Ding J, He P, Xiao C, Tang Z, Zhuang X, Chen X. J Control Release; 2011 Nov 30; 152 Suppl 1():e184-6. PubMed ID: 22195840 [No Abstract] [Full Text] [Related]
34. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Joe JH, Lee WM, Park YJ, Joe KH, Oh DH, Seo YG, Woo JS, Yong CS, Choi HG. Int J Pharm; 2010 Aug 16; 395(1-2):161-6. PubMed ID: 20580799 [Abstract] [Full Text] [Related]
35. Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: studies in rats. Ning M, Guo Y, Pan H, Yu H, Gu Z. Drug Deliv; 2005 Aug 16; 12(6):399-407. PubMed ID: 16253956 [Abstract] [Full Text] [Related]
36. Formulation parameters influencing the physicochemical characteristics of rosiglitazone-loaded cationic lipid emulsion. Davaa E, Park JS. Arch Pharm Res; 2012 Jul 16; 35(7):1205-13. PubMed ID: 22864743 [Abstract] [Full Text] [Related]
37. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies. Jordan F, Naylor A, Kelly CA, Howdle SM, Lewis A, Illum L. J Control Release; 2010 Jan 25; 141(2):153-60. PubMed ID: 19772878 [Abstract] [Full Text] [Related]
38. Development and characterization of nanoparticles of glibenclamide by solvent displacement method. Dora CP, Singh SK, Kumar S, Datusalia AK, Deep A. Acta Pol Pharm; 2010 Jan 25; 67(3):283-90. PubMed ID: 20524431 [Abstract] [Full Text] [Related]